Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three antibiotics—metronidazole, penicillin, and tobramycin. Each component has a distinct mechanism of action and antimicrobial spectrum:
This combination would provide broad-spectrum coverage against aerobic Gram-positive (penicillins), Gram-negative (tobramycin), and anaerobic organisms (metronidazole). Such combinations are sometimes used empirically for severe mixed infections or intra-abdominal infections where polymicrobial etiology is suspected.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on metronidazole + penicillin + tobramycin.